Rod Humerickhouse M.D., Asset Strategy Leader at ABBVIE discusses Venetoclax & Carfilzomib Dose Escalation Study At The 60th ASH Annual Meeting on Dec 1, 2018.
Venetoclax & Carfilzomib Dose Escalation Study
Rod Humerickhouse M.D., Asset Strategy Leader at ABBVIE discusses Venetoclax & Carfilzomib Dose Escalation Study At The 60th ASH Annual Meeting on Dec 1, 2018.